Publications by authors named "I Shirakawa"

Accumulation of lipotoxic lipids, such as free cholesterol, induces hepatocyte death and subsequent inflammation and fibrosis in the pathogenesis of nonalcoholic steatohepatitis (NASH). However, the underlying mechanisms remain unclear. We have previously reported that hepatocyte death locally induces phenotypic changes in the macrophages surrounding the corpse and remnant lipids, thereby promoting liver fibrosis in a murine model of NASH.

View Article and Find Full Text PDF

Accumulating evidence suggests that cholesterol accumulation in leukocytes is causally associated with the development of autoimmune diseases. However, the mechanism by which fatty acid composition influences autoimmune responses remains unclear. To determine whether the fatty acid composition of diet modulates leukocyte function and the development of systemic lupus erythematosus, we examined the effect of eicosapentaenoic acid (EPA) on the pathology of lupus in drug-induced and spontaneous mouse models.

View Article and Find Full Text PDF

A growing body of evidence indicates that cellular metabolism is involved in immune cell functions, including cytokine production. Serine is a nutritionally non-essential amino acid that can be generated by de novo synthesis and conversion from glycine. Serine contributes to various cellular responses, but the role in inflammatory responses remains poorly understood.

View Article and Find Full Text PDF
Article Synopsis
  • Nonalcoholic steatohepatitis (NASH) is linked to serious liver conditions like cirrhosis and liver cancer, and this study explores how certain diabetes drugs might help treat it.
  • Using a mouse model that mimics obesity and insulin resistance, researchers tested the DPP-4 inhibitor anagliptin, which showed promising results in preventing liver inflammation and cancer without significantly impacting body weight or overall metabolism.
  • The study suggests that anagliptin works by targeting macrophage activation in the liver, indicating that its benefits for NASH and liver cancer occur independently of its effects on glucose metabolism.
View Article and Find Full Text PDF

Non-alcoholic steatohepatitis (NASH), characterized by chronic inflammation and fibrosis, is predicted to be the leading cause of cirrhosis and hepatocellular carcinoma (HCC) in the next decade. Although recent evidence suggests the importance of fibrosis as the strongest determinant of HCC development, the molecular mechanisms underlying NASH-induced carcinogenesis still remain unclear. Here we performed RNA sequencing analysis to compare gene expression profiles of activated fibroblasts prepared from two distinct liver fibrosis models: carbon tetrachloride-induced fibrosis as a model without obesity and HCC and genetically obese melanocortin 4 receptor-deficient (MC4R-KO) mice fed Western diet, which develop steatosis, NASH, and eventually HCC.

View Article and Find Full Text PDF